Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

Surgical hair restoration has improved since 1959, with new techniques like minigrafts, micrografts, and scalp reductions creating more natural hairlines and reducing bald skin, despite some risks and potential for scarring.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

PRP therapy with minoxidil is more effective for hair growth than PRP alone.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Michael L. Beehner proposed a standardized way to describe balding areas on the scalp to help hair restoration experts communicate better.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

A man developed hair loss from testosterone treatment but improved with additional medication.

Most women have a widow's peak and specific hairline features useful for designing hair restoration surgery.

Scalp reduction surgery is safe and effective for certain patients with hair loss, leading to dense hair coverage and high satisfaction.

Scalp reduction gives the most natural result for significant crown baldness, despite potential complications, and a systematic approach to surgical hair restoration results in few complications and high graft survival.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The document concludes that successful hair restoration surgery should consider facial proportions and balance, and requires surgical skill, artistic judgment, and realistic goals for a natural look.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.